Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trial

• Published in: Frontiers in medicine Vol. 10; p. 1321303
• Main Authors: de Dios, Constanza, Vij, Ridhima, Kim, Hosu, Park, Hyeonggeun, Chang, Donna
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 2023
• Subjects: adipose-derived; COVID-19; intravenous; mesenchymal stem cells; safety; COVID-19; intravenous; mesenchymal stem cells; safety; adipose-derived

The purpose of the study was to assess the safety of allogeneic, Hope Biosciences Adipose Derived Mesenchymal Stem Cells (HB-adMSCs) for the treatment of hospitalized subjects with COVID-19.  = 48 patients were randomly assigned to HB-adMSC (100 MM) or placebo group. Four intravenous infusions of HB...